Risk of developing progressive multifocal leukoencephalopathy (PML) increases with increasing duration of exposure to Tysabri.

Related Posts:

1. Tysabri (Natalizumab): Update of Healthcare Professional Information
2. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
3. Recall to Repair: Whitco Company LP Stadium Light Poles Can Fall Over, Posing Risk of Serious Injury and Death
4. Benicar (olmesartan): Ongoing Safety Review
5. American Suzuki Motor Corp. Recalls QuadSport ATVs Due to Crash Hazard